Radiation Oncology (Mar 2023)
Correction: Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
- Masanori Hirata,
- Kazuaki Yasui,
- Naofumi Oota,
- Hirofumi Ogawa,
- Tsuyoshi Onoe,
- Sayo Maki,
- Yusuke Ito,
- Kenji Hayashi,
- Hirofumi Asakura,
- Shigeyuki Murayama,
- Koichi Mitsuya,
- Shoichi Deguchi,
- Katsumasa Nakamura,
- Nakamasa Hayashi,
- Tetsuo Nishimura,
- Hideyuki Harada
Affiliations
- Masanori Hirata
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Kazuaki Yasui
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Naofumi Oota
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Hirofumi Ogawa
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Tsuyoshi Onoe
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Sayo Maki
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Yusuke Ito
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Kenji Hayashi
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Hirofumi Asakura
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Shigeyuki Murayama
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Koichi Mitsuya
- Division of Neurosurgery, Shizuoka Cancer Center
- Shoichi Deguchi
- Division of Neurosurgery, Shizuoka Cancer Center
- Katsumasa Nakamura
- Department of Radiation Oncology, Hamamatsu University Hospital
- Nakamasa Hayashi
- Division of Neurosurgery, Shizuoka Cancer Center
- Tetsuo Nishimura
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- Hideyuki Harada
- Radiation and Proton Therapy Center, Shizuoka Cancer Center
- DOI
- https://doi.org/10.1186/s13014-023-02206-7
- Journal volume & issue
-
Vol. 18,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
